What's new in HER2+ mBC from ASCO 2023

 

What's new in HER2+ mBC from ASCO 2023
14:29

Jennifer Matro

Monitoring for Progression in HER2+ MBC: Are We Doing Enough?

  • 137 views
  • July 27, 2023
  • 3
09:52

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Patient Characteristics & Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ mBC"

FEATURING Jane Meisel
  • 274 views
  • July 24, 2023
  • 1
14:28

Fengting Yan

Surveying Efficacy Data of Anti-HER2 BC Therapies Beyond 1L Setting: Patient Selection & Sequencing

  • 37 views
  • July 9, 2023
06:37

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribociclib, Tucatinib, & Trastuzumab for HER2+ mBC & Phase 2 Study of Preoperative Treatment With Ribociclib, Trastuzumab, Tucatinib +/- Fulvestrant vs. Docetaxel, Carboplatin, Trastuzumab, & Pertuzumab for HR+/-, HER2+ BC"

FEATURING Nicholas McAndrew
  • 298 views
  • June 29, 2023
  • 1
08:41

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Randomized Trial - Nine-Weeks vs. One-Year Trastuzumab for Early-Stage HER2+ BC"

FEATURING Pierfranco Conte
  • 747 views
  • June 15, 2023
  • 3
07:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing Primary Tumor Resection + Systemic Therapy With Systemic Therapy Alone in mBC (PRIM-BC) - Japan Clinical Oncology Group Study JCOG1017"

FEATURING Tadahiko Shien
  • 345 views
  • June 14, 2023
  • 3
05:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With HER2+ Locally Advanced/Metastatic BC: OS Results of a Phase 3 Randomized Trial (JBCRG-M05: PRECIOUS)"

FEATURING Yutaka Yamamoto
  • 372 views
  • June 6, 2023
  • 1
14:35

Katarzyna Jerzak

Systemic Therapy for Patients With HER2+ mBC: The Impact of Brain Metastases on Treatment Sequencing

  • 143 views
  • April 7, 2023
  • 2
04:09

ecancer

Management of HER2+ mBC Treatment Algorithm

FEATURING Sandra Swain
  • 720 views
  • February 27, 2023
  • 7